Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06576830 · ClinicalTrials.gov registry record · Phase 4
Optimization of Pediatric Tonsillectomy to IMprove AnaLgesia
A Phase 4 study of Pain, Postoperative and Sleep Disordered Breathing, sponsored by Duke University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 440
- Enrollment target
- 1
- Study location
NCT06576830: Recruiting Phase 4 study of Pain, Postoperative and Sleep Disordered Breathing, sponsored by Duke University.
NCT06576830 is a Phase 4 study of Pain, Postoperative and Sleep Disordered Breathing that is actively recruiting participants, run by Duke University. The registered enrollment target is 440 participants, above the 269-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (64% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06576830, a Phase 4 study of Pain, Postoperative and Sleep Disordered Breathing, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 440 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the use of short acting opioids (fentanyl/hydromorphone) with long acting opioids (methadone) for pain control following tonsillectomy surgery in children and adolescents.
Primary Outcome
Binary (yes/no) need for opioid in the PACU
Conditions Studied
Interventions
- DRUG Methadone
- DRUG Fentanyl/Hydromorphone
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 440 participants |
| Start Date | 2024-11-21 |
| Est. Completion | 2029-06-01 |
| Phase | Phase 4 |
What NCT06576830 shows while recruiting
NCT06576830 is an interventional study that assigns participants to a tested intervention. The registered 440 participants enrollment target is mid-sized for trials with a published cap, above the 269-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (64% higher).
The record links to 5 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Methadone is the first listed.
NCT06576830 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06576830 about?
NCT06576830 is a clinical study titled "Optimization of Pediatric Tonsillectomy to IMprove AnaLgesia". The purpose of this study is to compare the use of short acting opioids (fentanyl/hydromorphone) with long acting opioids (methadone) for pain control following tonsillectomy surgery in children and adolescents.
What is the current status of trial NCT06576830?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 440 participants. The study started on 2024-11-21. Estimated completion is 2029-06-01.
What conditions does trial NCT06576830 study?
This clinical trial studies the following conditions: Pain, Postoperative, Sleep Disordered Breathing, Tonsillitis, Tonsillar Hypertrophy, Pediatric Sleep Apnea.
What interventions are being tested in trial NCT06576830?
The interventions under investigation include: Methadone (DRUG), Fentanyl/Hydromorphone (DRUG).
Who is sponsoring clinical trial NCT06576830?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06576830 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06576830's enrollment target sits among peer trials
440 8th of 113 higher than 106 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Management of Postoperative Discomfort in Young Children Following Dental Rehabilitation Under General Anesthesia
RECRUITING · Phase 4
-
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
RECRUITING · Phase 4
-
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
RECRUITING · Phase 4
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
RECRUITING · Phase 4
-
IPACK on Early Pain Scores After ACL Reconstruction
RECRUITING · Phase 4
-
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05114538 · 440 participants · NA
Improving the Part C Early Intervention Service Delivery System for Children with ASD
- NCT05117619 · 440 participants · NA
The HOME Program for Individuals With Traumatic Brain Injury and Family Members
- NCT05602194 · 440 participants · Phase 3
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
- NCT05624879 · 440 participants · NA
Accelerated Resolution Therapy for Early Maladaptive Grief
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI